Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
12 | 68808835 | intron variant | T/A | snv | 4.8E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
12 | 68808835 | intron variant | T/A | snv | 4.8E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
12 | 68826856 | intron variant | C/T | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 68826856 | intron variant | C/T | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 68839425 | missense variant | C/A;T | snv | 3.6E-05 | 7.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
12 | 68847050 | 3 prime UTR variant | A/G | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 68816914 | missense variant | G/C | snv | 4.0E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||||
|
12 | 68816914 | missense variant | G/C | snv | 4.0E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||||
|
12 | 68816914 | missense variant | G/C | snv | 4.0E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||||
|
0.882 | 0.040 | 12 | 68841626 | 3 prime UTR variant | G/A | snv | 0.35 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2014 | 2016 | |||||||
|
0.882 | 0.040 | 12 | 68841626 | 3 prime UTR variant | G/A | snv | 0.35 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2014 | 2016 | |||||||
|
0.882 | 0.040 | 12 | 68841626 | 3 prime UTR variant | G/A | snv | 0.35 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2014 | 2016 | |||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.882 | 0.040 | 12 | 68839592 | missense variant | A/G | snv | 1.2E-05 |
|
Neoplasms | 0.020 | 1.000 | 2 | 1999 | 2004 | |||||||
|
0.882 | 0.040 | 12 | 68820362 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.882 | 0.040 | 12 | 68820362 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.882 | 0.040 | 12 | 68820362 | missense variant | G/A | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.882 | 0.040 | 12 | 68841626 | 3 prime UTR variant | G/A | snv | 0.35 |
|
Neoplasms; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.040 | 12 | 68839357 | synonymous variant | T/C | snv | 1.8E-04 | 2.4E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.882 | 0.040 | 12 | 68839357 | synonymous variant | T/C | snv | 1.8E-04 | 2.4E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.882 | 0.040 | 12 | 68839357 | synonymous variant | T/C | snv | 1.8E-04 | 2.4E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.882 | 0.040 | 12 | 68809237 | missense variant | C/T | snv | 1.6E-04 | 1.9E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.882 | 0.040 | 12 | 68809237 | missense variant | C/T | snv | 1.6E-04 | 1.9E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.882 | 0.040 | 12 | 68809237 | missense variant | C/T | snv | 1.6E-04 | 1.9E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 |